What is Lifecore Biomedical, Inc.'s deferred revenue?

Lifecore Biomedical, Inc. (LFCR) reported deferred revenue of $5.86M in Q1 2026.

What is the long-term trend for Lifecore Biomedical, Inc.'s deferred revenue?

Over 4 years (2021 to 2026), Lifecore Biomedical, Inc.'s deferred revenue has grown at a 112.6% compound annual growth rate (CAGR), from $287K to $5.86M.

What does deferred revenue mean?

Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Lifecore Biomedical, Inc. LFCR Deferred Revenue

Deferred Revenue at other companies

Thermo Fisher ScientificTMO

$2.93B+2.2%

ADMA BiologicsADMA

$1.37M+857%

Medpace Holdings, Inc.MEDP

$856.34M+19.1%

Biodesix, Inc.BDSX

$223K-71.7%

ClearPoint NeuroCLPT

$1.81M+12.1%

Baxter InternationalBAX

——

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s deferred revenue?: Lifecore Biomedical, Inc. (LFCR) reported deferred revenue of $5.86M in Q1 2026.
What is the long-term trend for Lifecore Biomedical, Inc.'s deferred revenue?: Over 4 years (2021 to 2026), Lifecore Biomedical, Inc.'s deferred revenue has grown at a 112.6% compound annual growth rate (CAGR), from $287K to $5.86M.
What does deferred revenue mean?: Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.